US EUA For Lilly’s Bamlanivimab Conditioned On Additional GMP Compliance Requirements

 
• By Bowman Cox
  
Coronavirus
fda balances quality against availability of covid-19 neutralizing antibody
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance